Assignee
MARTIN ALAIN
12 patents
Top patents by PatentIndex Score
US7122578B2Oct 17, 2006
Method and composition for treating mammalian diseases and injuries which cause pain, erythema, swelling, crusting, ischemia scarring and excess white blood cell infiltration
MARTIN ALAIN8 citations74
US4682380AJul 28, 1987
Box for beekeeping for the creation of a bee colony, change of queen from a hive in activity and partial restriction of brood rearing
MARTIN ALAIN12 citations74
US10813893B2Oct 27, 2020
Compositions and methods for the treatment and prevention of chronic hypoxemia and dyspnea
MARTIN ALAIN2 citations73
US8211943B2Jul 3, 2012
Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells
MARTIN ALAIN3 citations63
US8114907B2Feb 14, 2012
Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells
MARTIN ALAIN5 citations63
US8076373B2Dec 13, 2011
Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite
MARTIN ALAIN6 citations63
US11666553B2Jun 6, 2023
Method of reducing anxiety in non-human mammals by increasing brain serotonin levels
MARTIN ALAIN0 citations62
US11464761B2Oct 11, 2022
Formulations for reducing anxiety in non-human mammals by increasing brain serotonin levels
MARTIN ALAIN1 citations62
US11458114B2Oct 4, 2022
Methods and compositions for enhancing synthesis secretion and transport of collagen to increase wound strength
MARTIN ALAIN0 citations62
US11628186B2Apr 18, 2023
Method and composition for the reduction of viral replication, duration and spread of the COVID-19 and the flu
MARTIN ALAIN0 citations52
US11311505B2Apr 26, 2022
Synergistic compositions to stimulate the synthesis of human lung and sinus surfactants to decrease coughing, increase FEV-1/FVC ratios, decrease lung fibrosis, by increasing apoptosis of myofibroblasts
MARTIN ALAIN0 citations52
US9675569B2Jun 13, 2017
Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells
MARTIN ALAIN0 citations52